Sonoran Biosciences, Inc.
Publicly observedTempe, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Tempe | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Sonoran Biosciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | NC7CCN6F16G1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant6 Sept 2022Publicly observed
NIH SBIR/STTR award: Extended-release injectable gel for multi-day treatment of postoperative pain
USD 1,009,908.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant6 Sept 2022Publicly observed
NIH SBIR/STTR award: Extended-release injectable gel for multi-day treatment of postoperative pain
USD 1,479,276.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.